Probi
Develops and manufactures clinically proven probiotics for B2B supplement & nutrition partners.
PROB | ST
Overview
Corporate Details
- ISIN(s):
- SE0001280355
- LEI:
- 5493004CJOCT273MU397
- Country:
- Sweden
- Address:
- Ideongatan 1A, 223 70 Lund
- Website:
- https://www.probi.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other food products
Description
Probi is an international biotechnology company that specializes in the research, development, and manufacturing of clinically documented probiotics and biotic solutions. The company operates on a B2B model, providing partners in the dietary supplement and nutrition industries with end-to-end services, from strain development to finished, private-label products. Probi's portfolio is segmented into specific health areas, including digestive, immune, metabolic, mental, and women's health, as well as solutions tailored for healthy aging and children. The firm emphasizes science-backed innovation and clinically proven efficacy for its products.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-02-03 09:20 |
Delisting Announcement
Avnotering av Probi
|
Swedish | 99.1 KB | ||
| 2025-02-03 09:20 |
Delisting Announcement
Delisting of Probi
|
English | 103.2 KB | ||
| 2025-01-22 15:55 |
Major Shareholding Notification
|
Swedish | 9.1 KB | ||
| 2025-01-21 09:47 |
Major Shareholding Notification
|
Swedish | 8.9 KB | ||
| 2025-01-20 22:01 |
Pre-Annual General Meeting Information
Notice of Extraordinary General Meeting in Probi AB (publ)
|
English | 123.5 KB | ||
| 2025-01-20 22:01 |
Pre-Annual General Meeting Information
Kallelse till extra bolagsstämma i Probi AB (publ)
|
Swedish | 82.2 KB | ||
| 2025-01-20 22:00 |
Delisting Announcement
Probi applies for delisting and convenes an Extraordinary General Meeting
|
English | 109.7 KB | ||
| 2025-01-20 22:00 |
Delisting Announcement
Probi ansöker om avnotering och kallar till extra bolagsstämma
|
Swedish | 104.6 KB | ||
| 2025-01-09 08:00 |
Report Publication Announcement
Probi senarelägger bokslutskommuniké för 2024
|
Swedish | 92.1 KB | ||
| 2025-01-09 08:00 |
Report Publication Announcement
Probi postpones year-end report 2024
|
English | 81.1 KB | ||
| 2025-01-09 08:00 |
Report Publication Announcement
Probi senarelägger bokslutskommuniké för 2024
|
Swedish | 92.1 KB | ||
| 2025-01-09 08:00 |
Report Publication Announcement
Probi postpones year-end report 2024
|
English | 81.1 KB | ||
| 2024-12-13 17:18 |
M&A Activity
Statement from the independent bid committee of Probi in relation to the public…
|
English | 142.9 KB | ||
| 2024-12-13 17:17 |
M&A Activity
Uttalande från den oberoende budkommittén i Probi med anledning av Symrise offe…
|
Swedish | 140.4 KB | ||
| 2024-11-20 07:20 |
M&A Activity
Probi’s Board comments on Symrise’s public takeover offer
|
English | 101.9 KB |
Automate Your Workflow. Get a real-time feed of all Probi filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Probi via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-30 | Jean-Yves Parisot | Other | Buy | 142,586 | 49,905,100.00 SEK |
| 2024-11-22 | Jean-Yves Parisot | Other | Buy | 42,076 | 14,726,600.00 SEK |
| 2024-11-21 | Jean-Yves Parisot | Other | Buy | 77,405 | 27,091,750.00 SEK |
| 2024-11-20 | Jean-Yves Parisot | Other | Buy | 169,053 | 59,168,550.00 SEK |
| 2022-05-06 | Henrik Lundkvist | Other | Buy | 100 | 27,981.00 SEK |
| 2022-04-29 | Tom Rönnlund | Other | Buy | 400 | 122,296.00 SEK |
| 2022-04-28 | Tom Rönnlund | Other | Buy | 955 | 287,015.70 SEK |
| 2020-05-06 | Tom Rönnlund | Other | Buy | 400 | 100,000.00 SEK |
